using Actos for more than one year may be associated with an increased risk of bladder cancer
Boston, MA (PRWEB) August 14, 2012
Gilman Law LLP has filed a lawsuit in California Superior Court, Fresno County, on behalf of a woman who developed bladder cancer while using the type 2 diabetes drug, Actos, for approximately 8 years. The lawsuit, which was filed on June 18, 2012, names Takeda Pharmaceuticals and its subsidiaries as Defendants (Case No. 12CE01901).
According to the lawsuit, Actos was approved to treat type 2 diabetes by the U.S. Food & Drug Administration (FDA) in 1999. The Plaintiff, a woman from Fresno County, California, took Actos as prescribed by her physician from November 5, 2003 through October/November 2011. She was caused to suffer bodily injury in or about April 29, 2009, including cancerous tumors on her bladder. The complaint alleges that the injuries and damages sustained by the Plaintiff were caused or substantially contributed to by the wrongful acts of Takeda Pharmaceuticals and other Defendants. Among other things, the lawsuit alleges that the product warnings for Actos in effect during the time the Plaintiff used the medication were inadequate to warn physicians or patients about the bladder cancer risk associated with Actos.
The complaint alleges that prior to receiving approval for Actos, Takeda and the other Defendants possessed evidence, including animal studies, which Defendants should have known was a signal that bladder cancer risk needed to be further studied before Actos could be placed on the market. The lawsuits also claim that bladder cancer evidence from human clinical trials became known to the Defendants in the early 2000s. It wasn’t until June 15, 2011 that the FDA issued a Drug Safety Communication warning that using Actos for more than one year may be associated with an increased risk of bladder cancer, according to the complaint.
Since the FDA issued its warning last June, numerous lawsuits have been filed in state and federal courts throughout the U.S. Federal Actos bladder cancer lawsuits have been consolidated in a multidistrict litigation in U.S. District Court, Western District of Louisiana, before the Honorable Judge Rebecca Doherty (MDL No. 2299). On June 13, Judge Doherty issued an order stating that the litigation’s first trial would begin on November 3, 2014. Bloomberg News reported in March that legal experts expect that Takeda could eventually be named in as many as 10,000 Actos bladder cancer lawsuits.
Gilman Law LLP is providing free legal consultations to victims of Actos bladder cancer. The firm urges anyone who was diagnosed with bladder cancer during or after treatment with Actos to seek legal counsel immediately. Statues of limitations for filing Actos bladder cancer lawsuits may soon expire in some states, and could jeopardize Plaintiffs’ ability to recover any compensation from Takeda Pharmaceuticals. For a free Actos bladder cancer lawsuit consultation, please contact Gilman Law LLP by visiting Gilmanlawllp.com, or call Toll Free at 1-888-252-0048.
About Gilman Law LLP
Gilman Law LLP, a leading national law firm with offices in Florida and Massachusetts, has been recognized for delivering successful results to their clients across a broad range of claims stemming from consumer product injury, mass tort, and class action lawsuits. For over 32 years, the Gilman Law LLP team of highly experienced lawyers has earned renown for tireless work on behalf of their clients on many of today’s most challenging and important legal issues.
Gilman Law LLP
Beachway Professional Center Tower
3301 Bonita Beach Road
Bonita Springs, FL 34134